No-carrier-added synthesis of a 4-methyl-substituted meta- iodobenzylguanidine analogue

Applied Radiation and Isotopes

Volumn 62, Issue 3, 2005, Pages 435-440

  Vaidyanathan, G ^a   Affleck, D J ^a   Zalutsky, M R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

3 iodo 4 methylbenzylguanidine; Iododestannylation; MIBG; Neuroblastoma

Indexed keywords

NEUROENDOCRINE TUMORS; TIN PRECURSORS;

SYNTHESIS (CHEMICAL); TUMORS;

AROMATIC HYDROCARBONS;

(3 IODOBENZYL)GUANIDINE I 131; 3 IODO 4 METHYLBENZYLALCOHOL; ALCOHOL DERIVATIVE; DRUG CARRIER; FUNCTIONAL GROUP; GUANIDINE DERIVATIVE; N,N' BIS(TERT BUTYLOXYCARBONYL) N (4 METHYL 3 TRIMETHYLSTANNYLBENZYL) GUANIDINE; TIN; TRACER; UNCLASSIFIED DRUG;

ADDITION REACTION; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; ISOTOPE LABELING; NEUROBLASTOMA; PRECURSOR; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOIODINATION; SUBSTITUTION REACTION;

3-IODOBENZYLGUANIDINE; CELL LINE, TUMOR; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; NEUROBLASTOMA; RADIOPHARMACEUTICALS;

EID: 10644242760     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.07.001     Document Type: Article

References (25)

1. J.N. Biedler, L. Helson, and B.A. Spengler Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture Cancer Res. 33 1973 2643 2652
2. M.H. Block, S. Boyer, W. Brailsford, D.R. Brittain, D. Carroll, S. Chapman, D.S. Clarke, C.S. Donald, K.M. Foote, L. Godfrey, A. Ladner, P.R. Marsham, D.J. Masters, C.D. Mee, M.R. O'Donovan, J.E. Pease, A.G. Pickup, J.W. Rayner, A. Roberts, P. Schofield, A. Suleman, and A.V. Turnbull Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity J. Med. Chem. 45 2002 3509 3523
3. P.L. Cummins, and J.E. Gready Computer-aided drug design a free energy perturbation study on the binding of methyl-substituted pterins and N5-deazapterins to dihydrofolate reductase J. Comput. Aid. Mol. Des. 7 1993 535 555
4. D.S. Dodd, and A.P. Kozikowski Conversion of alcohols to protected guanidines using the Mitsunobu protocol Tetrahedron Lett 35 1994 977 980
5. N. Hattori, and M. Schwaiger Metaiodobenzylguanidine scintigraphy of the heart what have we learnt clinically? Eur. J. Nucl. Med. 27 2000 1 6
6. S. Jaques Jr., M.C. Tobes, J.C. Sisson, J.A. Baker, and D.M. Wieland Comparison of the sodium dependency of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells Mol. Pharmacol. 26 1984 539 546
7. 125I]N- (diethylaminoethyl)-4-iodobenzamide a potential ligand for imaging malignant melanoma Nucl. Med. Biol. 20 1993 75 79
8. J.P. Kaltenbach, M.H. Kaltenbach, and W.B. Lyons Nigrosin as a dye for differentiating live and dead ascites cells Exp. Cell. Res. 15 1958 112 117
9. 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma, J Clin. Oncol. 16 1998 229 236
10. Moerlein, S.M., Coenen, H.H., 1985. Regiospecific no-carrier-added radiobromination and radioiodination of aryltrimethyl group IVb organometallics. J. Chem. Soc. Perkin. Trans. I 1941-1947.
11. 131I-mIBG) Clin. Endocrinol. 55 2001 47 60
12. A.D. Patel, and A.E. Iskandrian MIBG imaging J. Nucl. Cardiol. 9 2002 75 94
13. I. Sircar, B.L. Duell, G. Bobowski, J.A. Bristol, and D.B. Evans Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones a new class of positive inotropic agents J. Med. Chem. 28 1985 1405 1413
14. J.C. Sisson, and B.L. Shulkin Nuclear medicine imaging of pheochromocytoma and neuroblastoma Q. J. Nucl. Med. 43 1999 217 223
15. L.A. Smets, C. Loesberg, M. Janssen, E.A. Metwally, and R. Huiskamp Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells Cancer Res 49 1989 2941 2944
16. 131I-MIBG J. Nucl. Med. 42 2001 237 247
17. 131I MIBG therapy in neuroblastoma, mechanisms, rationale, and current status Med. Pediatr. Oncol. 32 1999 427 431
18. D. Tourwe, E. Mannekens, T. Nguyen Thi Diem, P. Verheyden, H. Jaspers, G. Toth, A. Peter, I. Kertesz, G. Torok, N.N. Chung, and P.W. Schiller Side chain methyl substitution in the δ-opioid receptor antagonist TIPP has an important effect on the activity profile J. Med. Chem. 41 1998 5167 5176
19. 131I]iodobenzylguanidine Appl. Radiat. Isot. 44 1993 621 628
20. G. Vaidyanathan, S. Shankar, D.J. Affleck, P.C. Welsh, S.K. Slade, and M.R. Zalutsky Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues Bioconjugate Chem 12 2001 798 806
21. G. Vaidyanathan, S. Shankar, D.J. Affleck, K. Alston, J. Norman, P. Welsh, H. LeGrand, and M.R. Zalutsky Meta-iodobenzylguanidine derivatives containing a second guanidine moiety Bioorgan. Med. Chem. 12 2004 1649 1656
22. 131I]iodobenzylguanidine J. Nucl. Med. 21 1980 349 353
23. D.M. Wieland Radiopharmaceutical Design the adrenal medulla and its diseases A.R. Fritzberg Radiopharmaceuticals Progress and Clinical Perspectives Vol. 1 1986 CRC Press, Inc Boca Raton, FL 117 153
24. D.S. Wilbur, S.W. Hadley, M.D. Hylarides, P.G. Abrams, P.A. Beaumier, A.C. Morgan, J.M. Reno, and A.R. Fritzberg Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer J. Nucl. Med. 20 1989 216 226
25. G.A. Yanik, J.E. Levine, K.K. Matthay, J.C. Sisson, B.L. Shulkin, B. Shapiro, D. Hubers, S. Spalding, T. Braun, J.L.M. Ferrara, and R.J. Hutchinson Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma J. Clin. Oncol. 20 2002 2142 2149